Microarray patch transdermal drug delivery systems consist of tiny protrusions that stick to the body like small bandages that painlessly penetrate the outermost layer of the skin to deliver the drug or vaccine to the top layer of the skin. This drug delivery system is simpler than traditional drug delivery methods and can also reduce a certain risk of infection, ensuring the safety of patients.
The global market for Microarray Patch Transdermal Drug Delivery Systems was estimated to be worth US$ 5615 million in 2023 and is forecast to a readjusted size of US$ 8345 million by 2030 with a CAGR of 6.3% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Microarray Patch Transdermal Drug Delivery Systems, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Microarray Patch Transdermal Drug Delivery Systems by region & country, by Type, and by Application.
The Microarray Patch Transdermal Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microarray Patch Transdermal Drug Delivery Systems.
Market Segmentation
By Company
3M
Becton
Endoderma
BD
Raphas
Nanopass Tech
Corium International
Nitto Denko
Microdermics
TheraJect
Vaxxas
KINDEVA
QuadMedicine
Lohmann Therapie-Systeme
AdminMed Nano BioSciences
Segment by Type:
Solid Microneedles
Hollow Microneedles
Dissolving Microneedles
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Microarray Patch Transdermal Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Microarray Patch Transdermal Drug Delivery Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Microarray Patch Transdermal Drug Delivery Systems in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Microarray Patch Transdermal Drug Delivery Systems Product Introduction
1.2 Global Microarray Patch Transdermal Drug Delivery Systems Market Size Forecast
1.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value (2019-2030)
1.2.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume (2019-2030)
1.2.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales Price (2019-2030)
1.3 Microarray Patch Transdermal Drug Delivery Systems Market Trends & Drivers
1.3.1 Microarray Patch Transdermal Drug Delivery Systems Industry Trends
1.3.2 Microarray Patch Transdermal Drug Delivery Systems Market Drivers & Opportunity
1.3.3 Microarray Patch Transdermal Drug Delivery Systems Market Challenges
1.3.4 Microarray Patch Transdermal Drug Delivery Systems Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Microarray Patch Transdermal Drug Delivery Systems Players Revenue Ranking (2023)
2.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Company (2019-2024)
2.3 Global Microarray Patch Transdermal Drug Delivery Systems Players Sales Volume Ranking (2023)
2.4 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume by Company Players (2019-2024)
2.5 Global Microarray Patch Transdermal Drug Delivery Systems Average Price by Company (2019-2024)
2.6 Key Manufacturers Microarray Patch Transdermal Drug Delivery Systems Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Microarray Patch Transdermal Drug Delivery Systems Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Microarray Patch Transdermal Drug Delivery Systems
2.9 Microarray Patch Transdermal Drug Delivery Systems Market Competitive Analysis
2.9.1 Microarray Patch Transdermal Drug Delivery Systems Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Microarray Patch Transdermal Drug Delivery Systems Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microarray Patch Transdermal Drug Delivery Systems as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Solid Microneedles
3.1.2 Hollow Microneedles
3.1.3 Dissolving Microneedles
3.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value by Type
3.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value, by Type (2019-2030)
3.2.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value, by Type (%) (2019-2030)
3.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume by Type
3.3.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume, by Type (2019-2030)
3.3.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume, by Type (%) (2019-2030)
3.4 Global Microarray Patch Transdermal Drug Delivery Systems Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgical Centers
4.1.3 Specialty Clinics
4.1.4 Others
4.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value by Application
4.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value, by Application (2019-2030)
4.2.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value, by Application (%) (2019-2030)
4.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume by Application
4.3.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume, by Application (2019-2030)
4.3.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume, by Application (%) (2019-2030)
4.4 Global Microarray Patch Transdermal Drug Delivery Systems Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value by Region
5.1.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value by Region (2019-2024)
5.1.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value by Region (2025-2030)
5.1.4 Global Microarray Patch Transdermal Drug Delivery Systems Sales Value by Region (%), (2019-2030)
5.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume by Region
5.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume by Region (2019-2024)
5.2.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume by Region (2025-2030)
5.2.4 Global Microarray Patch Transdermal Drug Delivery Systems Sales Volume by Region (%), (2019-2030)
5.3 Global Microarray Patch Transdermal Drug Delivery Systems Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Microarray Patch Transdermal Drug Delivery Systems Sales Value, 2019-2030
5.4.2 North America Microarray Patch Transdermal Drug Delivery Systems Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Microarray Patch Transdermal Drug Delivery Systems Sales Value, 2019-2030
5.5.2 Europe Microarray Patch Transdermal Drug Delivery Systems Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Sales Value, 2019-2030
5.6.2 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Microarray Patch Transdermal Drug Delivery Systems Sales Value, 2019-2030
5.7.2 South America Microarray Patch Transdermal Drug Delivery Systems Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Microarray Patch Transdermal Drug Delivery Systems Sales Value, 2019-2030
5.8.2 Middle East & Africa Microarray Patch Transdermal Drug Delivery Systems Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Microarray Patch Transdermal Drug Delivery Systems Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Microarray Patch Transdermal Drug Delivery Systems Sales Value
6.2.1 Key Countries/Regions Microarray Patch Transdermal Drug Delivery Systems Sales Value, 2019-2030
6.2.2 Key Countries/Regions Microarray Patch Transdermal Drug Delivery Systems Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Microarray Patch Transdermal Drug Delivery Systems Sales Value, 2019-2030
6.3.2 United States Microarray Patch Transdermal Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Microarray Patch Transdermal Drug Delivery Systems Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Microarray Patch Transdermal Drug Delivery Systems Sales Value, 2019-2030
6.4.2 Europe Microarray Patch Transdermal Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Microarray Patch Transdermal Drug Delivery Systems Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Microarray Patch Transdermal Drug Delivery Systems Sales Value, 2019-2030
6.5.2 China Microarray Patch Transdermal Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.5.3 China Microarray Patch Transdermal Drug Delivery Systems Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Microarray Patch Transdermal Drug Delivery Systems Sales Value, 2019-2030
6.6.2 Japan Microarray Patch Transdermal Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Microarray Patch Transdermal Drug Delivery Systems Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Microarray Patch Transdermal Drug Delivery Systems Sales Value, 2019-2030
6.7.2 South Korea Microarray Patch Transdermal Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Microarray Patch Transdermal Drug Delivery Systems Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Microarray Patch Transdermal Drug Delivery Systems Sales Value, 2019-2030
6.8.2 Southeast Asia Microarray Patch Transdermal Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Microarray Patch Transdermal Drug Delivery Systems Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Microarray Patch Transdermal Drug Delivery Systems Sales Value, 2019-2030
6.9.2 India Microarray Patch Transdermal Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.9.3 India Microarray Patch Transdermal Drug Delivery Systems Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 3M
7.1.1 3M Company Information
7.1.2 3M Introduction and Business Overview
7.1.3 3M Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.1.4 3M Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.1.5 3M Recent Development
7.2 Becton
7.2.1 Becton Company Information
7.2.2 Becton Introduction and Business Overview
7.2.3 Becton Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Becton Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.2.5 Becton Recent Development
7.3 Endoderma
7.3.1 Endoderma Company Information
7.3.2 Endoderma Introduction and Business Overview
7.3.3 Endoderma Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Endoderma Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.3.5 Endoderma Recent Development
7.4 BD
7.4.1 BD Company Information
7.4.2 BD Introduction and Business Overview
7.4.3 BD Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.4.4 BD Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.4.5 BD Recent Development
7.5 Raphas
7.5.1 Raphas Company Information
7.5.2 Raphas Introduction and Business Overview
7.5.3 Raphas Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Raphas Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.5.5 Raphas Recent Development
7.6 Nanopass Tech
7.6.1 Nanopass Tech Company Information
7.6.2 Nanopass Tech Introduction and Business Overview
7.6.3 Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.6.5 Nanopass Tech Recent Development
7.7 Corium International
7.7.1 Corium International Company Information
7.7.2 Corium International Introduction and Business Overview
7.7.3 Corium International Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Corium International Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.7.5 Corium International Recent Development
7.8 Nitto Denko
7.8.1 Nitto Denko Company Information
7.8.2 Nitto Denko Introduction and Business Overview
7.8.3 Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.8.5 Nitto Denko Recent Development
7.9 Microdermics
7.9.1 Microdermics Company Information
7.9.2 Microdermics Introduction and Business Overview
7.9.3 Microdermics Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Microdermics Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.9.5 Microdermics Recent Development
7.10 TheraJect
7.10.1 TheraJect Company Information
7.10.2 TheraJect Introduction and Business Overview
7.10.3 TheraJect Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.10.4 TheraJect Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.10.5 TheraJect Recent Development
7.11 Vaxxas
7.11.1 Vaxxas Company Information
7.11.2 Vaxxas Introduction and Business Overview
7.11.3 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.11.5 Vaxxas Recent Development
7.12 KINDEVA
7.12.1 KINDEVA Company Information
7.12.2 KINDEVA Introduction and Business Overview
7.12.3 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.12.4 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.12.5 KINDEVA Recent Development
7.13 QuadMedicine
7.13.1 QuadMedicine Company Information
7.13.2 QuadMedicine Introduction and Business Overview
7.13.3 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.13.4 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.13.5 QuadMedicine Recent Development
7.14 Lohmann Therapie-Systeme
7.14.1 Lohmann Therapie-Systeme Company Information
7.14.2 Lohmann Therapie-Systeme Introduction and Business Overview
7.14.3 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.14.5 Lohmann Therapie-Systeme Recent Development
7.15 AdminMed Nano BioSciences
7.15.1 AdminMed Nano BioSciences Company Information
7.15.2 AdminMed Nano BioSciences Introduction and Business Overview
7.15.3 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.15.4 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Product Offerings
7.15.5 AdminMed Nano BioSciences Recent Development
8 Industry Chain Analysis
8.1 Microarray Patch Transdermal Drug Delivery Systems Industrial Chain
8.2 Microarray Patch Transdermal Drug Delivery Systems Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Microarray Patch Transdermal Drug Delivery Systems Sales Model
8.5.2 Sales Channel
8.5.3 Microarray Patch Transdermal Drug Delivery Systems Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
3M
Becton
Endoderma
BD
Raphas
Nanopass Tech
Corium International
Nitto Denko
Microdermics
TheraJect
Vaxxas
KINDEVA
QuadMedicine
Lohmann Therapie-Systeme
AdminMed Nano BioSciences
听
听
*If Applicable.
